Nicholas A.J. Botwood's most recent trade in Syndax Pharmaceuticals Inc was a trade of 11,765 Common Stock done at an average price of $9.0 . Disclosure was reported to the exchange on May 16, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals Inc | Nicholas A.J. Botwood | Head of R&D, CMO | Purchase of securities on an exchange or from another person at price $ 8.99 per share. | 16 May 2025 | 11,765 | 35,165 (0%) | 0% | 9.0 | 105,826 | Common Stock |